Literature DB >> 21509883

Quantification of background enhancement in breast magnetic resonance imaging.

C Klifa1, S Suzuki, S Aliu, L Singer, L Wilmes, D Newitt, B Joe, N Hylton.   

Abstract

PURPOSE: To present a novel technique for measuring tissue enhancement in breast fibroglandular tissue regions on contrast-enhanced breast magnetic resonance imaging (MRI) aimed at quantifying the enhancement of breast parenchyma, also known as "background enhancement."
MATERIALS AND METHODS: Our quantitative method for measuring breast MRI background enhancement was evaluated in a population of 16 healthy volunteers. We also demonstrate the use of our new technique in the case study of one subject classified as high risk for developing breast cancer who underwent 3 months of tamoxifen therapy.
RESULTS: We obtained quantitative measures of background enhancement in all cases. The high-risk patient exhibited a 37% mean reduction in background enhancement with treatment.
CONCLUSION: Our quantitative method is a robust and promising tool that may allow investigators to quantify and document the potential adverse effect of background enhancement on diagnostic accuracy in larger populations.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509883      PMCID: PMC3081108          DOI: 10.1002/jmri.22545

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  17 in total

1.  Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ.

Authors:  Anjali S Kumar; Daniel F Chen; Alfred Au; Yunn-Yi Chen; Jessica Leung; Elisabeth R Garwood; Jessica Gibbs; Nola Hylton; Laura J Esserman
Journal:  Am J Surg       Date:  2006-10       Impact factor: 2.565

2.  Meta-analysis of MR imaging in the diagnosis of breast lesions.

Authors:  Nicky H G M Peters; Inne H M Borel Rinkes; Nicolaas P A Zuithoff; Willem P T M Mali; Karel G M Moons; Petra H M Peeters
Journal:  Radiology       Date:  2007-11-16       Impact factor: 11.105

Review 3.  Diagnostic breast MR imaging: current status and future directions.

Authors:  Elizabeth A Morris
Journal:  Radiol Clin North Am       Date:  2007-09       Impact factor: 2.303

4.  Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle.

Authors:  Richard L Ellis
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

5.  Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging.

Authors:  L Esserman; N Hylton; L Yassa; J Barclay; S Frankel; E Sickles
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

6.  [MR imaging of the breast before and after neoadjuvant treatment - enhancement characteristics and T 2 signal intensity of breast cancers and breast parenchyma].

Authors:  K C Siegmann; K-T Müller; U Vogel; K Krauss; C D Claussen
Journal:  Rofo       Date:  2009-12-01

7.  Correlation between breast density in mammography and background enhancement in MR mammography.

Authors:  R Cubuk; N Tasali; B Narin; F Keskiner; L Celik; S Guney
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

8.  Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T.

Authors:  Andrea Teifke; Alexander Hlawatsch; Thomas Beier; Toni Werner Vomweg; Simin Schadmand; Markus Schmidt; Hans-Anton Lehr; Manfred Thelen
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

9.  The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?

Authors:  V Craig Jordan
Journal:  J Clin Oncol       Date:  2008-06-02       Impact factor: 44.544

10.  Suppression of unspecific enhancement on breast magnetic resonance imaging (MRI) by antiestrogen medication.

Authors:  Anke Heinig; Dieter Lampe; Heinz Kölbl; Rainer Beck; Sylvia H Heywang-Köbrunner
Journal:  Tumori       Date:  2002 May-Jun
View more
  12 in total

1.  Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI.

Authors:  Jeon-Hor Chen; Hon Yu; Muqing Lin; Rita S Mehta; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2013-08-29       Impact factor: 2.546

Review 2.  Evaluation of background parenchymal enhancement on breast MRI: a systematic review.

Authors:  Bianca Bignotti; Alessio Signori; Francesca Valdora; Federica Rossi; Massimo Calabrese; Manuela Durando; Giovanna Mariscotto; Alberto Tagliafico
Journal:  Br J Radiol       Date:  2016-12-07       Impact factor: 3.039

Review 3.  Background parenchymal enhancement on breast MRI: A comprehensive review.

Authors:  Geraldine J Liao; Leah C Henze Bancroft; Roberta M Strigel; Rhea D Chitalia; Despina Kontos; Linda Moy; Savannah C Partridge; Habib Rahbar
Journal:  J Magn Reson Imaging       Date:  2019-04-19       Impact factor: 4.813

4.  Breast MRI Background Parenchymal Enhancement Categorization Using Deep Learning: Outperforming the Radiologist.

Authors:  Sarah Eskreis-Winkler; Elizabeth J Sutton; Donna D'Alessio; Katherine Gallagher; Nicole Saphier; Joseph Stember; Danny F Martinez; Elizabeth A Morris; Katja Pinker
Journal:  J Magn Reson Imaging       Date:  2022-02-15       Impact factor: 5.119

5.  Three-Dimensional Whole Breast Segmentation in Sagittal and Axial Breast MRI With Dense Depth Field Modeling and Localized Self-Adaptation for Chest-Wall Line Detection.

Authors:  Dong Wei; Susan Weinstein; Meng-Kang Hsieh; Lauren Pantalone; Despina Kontos
Journal:  IEEE Trans Biomed Eng       Date:  2018-10-15       Impact factor: 4.538

6.  Fully automatic quantification of fibroglandular tissue and background parenchymal enhancement with accurate implementation for axial and sagittal breast MRI protocols.

Authors:  Dong Wei; Nariman Jahani; Eric Cohen; Susan Weinstein; Meng-Kang Hsieh; Lauren Pantalone; Despina Kontos
Journal:  Med Phys       Date:  2020-11-27       Impact factor: 4.071

7.  Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.

Authors:  Natsuko Onishi; Wen Li; David C Newitt; Roy J Harnish; Fredrik Strand; Alex Anh-Tu Nguyen; Vignesh Amal Arasu; Jessica Gibbs; Ella F Jones; Lisa J Wilmes; John Kornak; Bonnie N Joe; Elissa R Price; Haydee Ojeda-Fournier; Mohammad Eghtedari; Kathryn W Zamora; Stefanie Woodard; Heidi R Umphrey; Michael T Nelson; An L Church; Patrick J Bolan; Theresa Kuritza; Kathleen Ward; Kevin Morley; Dulcy Wolverton; Kelly Fountain; Dan Lopez Paniagua; Lara Hardesty; Kathleen R Brandt; Elizabeth S McDonald; Mark Rosen; Despina Kontos; Hiroyuki Abe; Deepa Sheth; Erin Crane; Charlotte Dillis; Pulin Sheth; Linda Hovanessian-Larsen; Dae Hee Bang; Bruce Porter; Karen Y Oh; Neda Jafarian; Luminita A Tudorica; Bethany Niell; Jennifer Drukteinis; Mary S Newell; Marina E Giurescu; Elise Berman; Constance D Lehman; Savannah C Partridge; Kimberly A Fitzpatrick; Marisa H Borders; Wei Tse Yang; Basak Dogan; Sally Hayward Goudreau; Thomas Chenevert; Christina Yau; Angela DeMichele; Donald A Berry; Laura J Esserman; Nola M Hylton
Journal:  Radiology       Date:  2021-08-24       Impact factor: 29.146

8.  Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Authors:  Jeon Hor Chen; Hon J Yu; Christine Hsu; Rita S Mehta; Philip M Carpenter; Min Ying Su
Journal:  Transl Oncol       Date:  2015-06       Impact factor: 4.243

9.  Analysis of background parenchymal echogenicity on breast ultrasound: Correlation with mammographic breast density and background parenchymal enhancement on magnetic resonance imaging.

Authors:  Kyung Hee Ko; Hae Kyoung Jung; Inwha Kim
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 10.  Clinical application of magnetic resonance imaging in management of breast cancer patients receiving neoadjuvant chemotherapy.

Authors:  Jeon-Hor Chen; Min-Ying Su
Journal:  Biomed Res Int       Date:  2013-06-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.